10.1371/journal.pone.0137870.t001 Yanhong Yuan Yanhong Yuan Xiajing Che Xiajing Che Zhaohui Ni Zhaohui Ni Yifei Zhong Yifei Zhong Yinghui Qi Yinghui Qi Xinghua Shao Xinghua Shao Qin Wang Qin Wang Liou Cao Liou Cao Minfang Zhang Minfang Zhang Yuanyuan Xie Yuanyuan Xie Chaojun Qi Chaojun Qi Lei Tian Lei Tian Shan Mou Shan Mou Demographics and Clinicopathologic Characteristics of Patients with IgAN. Public Library of Science 2015 diastolic blood pressure 489 patients validation cohort.ConclusionsThis study Current Therapy Regimen baseline diastolic blood pressure Ren Ji Hospital dbp igan multivariate Cox analysis relapse 2015-09-15 03:13:46 Dataset https://plos.figshare.com/articles/dataset/_Demographics_and_Clinicopathologic_Characteristics_of_Patients_with_IgAN_/1545150 <p>Values are presented as the means ± standard deviation (SD) if the variables showed a normal distribution and as medians (IQR) if the variables did not show a normal distribution; n (%) was used for the categorical variables.</p><p>SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial blood pressure; SCr: serum creatinine; BUN: blood urea nitrogen; eGFR: estimated glomerular filtration rate; UA: serum uric acid; Hb: hemoglobin; ALB: serum albumin; UPE: 24-h urinary protein excretion; uRBC/HP: hematuria; TA-ALB: time-averaged serum albumin; TA-SCr: time-averaged serum creatinine; TA-eGFR: time-averaged eGFR; TA-UPE: time-averaged 24-h urinary protein excretion; Peak UPE: maximum level of UPE during follow-up; Peak SCr: maximum level of SCr during follow-up; Minimum ALB: minimum level of ALB; Minimum eGFR: minimum eGFR during follow-up; UPE ratio: (UPE at follow-up—baseline UPE) / baseline UPE.</p><p>Demographics and Clinicopathologic Characteristics of Patients with IgAN.</p>